These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9215609)

  • 21. Acute myeloblastic leukemia.
    Molina CA; Rodríguez MJ; de Marcos NS; Font P
    Adv Ther; 2011 Mar; 28 Suppl 3():10-6. PubMed ID: 21431629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of myelodysplasia/acute myeloid leukemia 'on therapy' in two patients with acute promyelocytic leukemia.
    Chelghoum Y; Plesa A; Ducastelle S; Elhamri M; Thomas X
    Indian J Cancer; 2016; 53(1):59-60. PubMed ID: 27146742
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic effects of low-dose cytosine arabinoside, alpha-interferon, 1 alpha-hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes.
    Hellström E; Robèrt KH; Gahrton G; Mellstedt H; Lindemalm C; Einhorn S; Björkholm M; Grimfors G; Udén AM; Samuelsson J
    Eur J Haematol; 1988 May; 40(5):449-59. PubMed ID: 3378598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation in acute myeloid leukemia and myelodysplastic disorders. Is differentiation-induction therapy possible?
    Januszewicz EH; Firkin FC
    Aust N Z J Med; 1988 Aug; 18(5):705-11. PubMed ID: 3072952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low dose cytosine arabinoside in myelodysplasia and acute myelogenous leukemia: a review.
    Bolwell BJ; Cassileth PA; Gale RP
    Leukemia; 1987 Aug; 1(8):575-9. PubMed ID: 3312846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia.
    Frankel A; Liu JS; Rizzieri D; Hogge D
    Leuk Lymphoma; 2008 Mar; 49(3):543-53. PubMed ID: 18297533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very-low-dose cytarabine for myelodysplastic syndromes and acute myeloid leukaemia in the elderly.
    Worsley A; Mufti GJ; Copplestone JA; Oscier DG; Hamblin TJ
    Lancet; 1986 Apr; 1(8487):966. PubMed ID: 2871254
    [No Abstract]   [Full Text] [Related]  

  • 28. Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes.
    Kim M; Williams S
    Ann Pharmacother; 2018 Aug; 52(8):792-800. PubMed ID: 29532662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine].
    Waage A; Hammerstrøm J; Lødemel B; Hoff JE; Langtind J
    Tidsskr Nor Laegeforen; 1986 Feb; 106(6):496-7. PubMed ID: 3457484
    [No Abstract]   [Full Text] [Related]  

  • 30. Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes.
    Murray M; Sarsfield P; Lawlor E; McCann SR
    Ir J Med Sci; 1988 Jul; 157(7):238-41. PubMed ID: 3170148
    [No Abstract]   [Full Text] [Related]  

  • 31. Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.
    Merkel D; Filanovsky K; Gafter-Gvili A; Vidal L; Aviv A; Gatt ME; Silbershatz I; Herishanu Y; Arad A; Tadmor T; Dally N; Nemets A; Rouvio O; Ronson A; Herzog-Tzarfati K; Akria L; Braester A; Hellmann I; Yeganeh S; Nagler A; Leiba R; Mittelman M; Ofran Y
    Am J Hematol; 2013 Feb; 88(2):130-4. PubMed ID: 23345248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopenia.
    Zhang W; Liu C; Wu D; Liang C; Zhang L; Zhang Q; Liu Y; Xia M; Wang H; Su P; Feng S; Han M; Zhou J; Wang F; Jiang E
    Blood Cells Mol Dis; 2019 May; 76():66-71. PubMed ID: 30846359
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic effectiveness of vitamin D3 in patients with myelodysplastic syndromes, leukemias and myeloproliferative disorders].
    Takahashi T; Ichiba S; Okuno Y; Sugiyama H; Sakai Y; Imura H; Iho S; Hoshino T; Suzuki A; Okada T
    Rinsho Ketsueki; 1989 Jan; 30(1):1-10. PubMed ID: 2716194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP; Hirji K; Itri L
    Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of low-dose Ara-C in the treatment of refractory, atypical leukemia and myelodysplastic syndrome].
    Tsubaki K; Horiuchi A; Nagai K; Kanamaru A; Kohsaki M; Kitani T; Tagawa S; Masaoka T; Shibata H; Yasunaga K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):996-1003. PubMed ID: 3457553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndrome.
    Ofran Y; Filanovsky K; Gafter-Gvili A; Vidal L; Aviv A; Gatt ME; Silbershatz I; Herishanu Y; Arad A; Tadmor T; Dally N; Nemets A; Rouvio O; Ronson A; Herzog-Tzarfati K; Akria L; Braester A; Hellmann I; Yeganeh S; Nagler A; Leiba R; Mittelman M; Merkel D
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e95-9. PubMed ID: 25819366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure.
    Prebet T; Charbonnier A; Gelsi-Boyer V; Mozziconacci MJ; Blaise D; Vey N
    Leuk Lymphoma; 2013 Jul; 54(7):1538-40. PubMed ID: 23110702
    [No Abstract]   [Full Text] [Related]  

  • 38. PARP inhibitors-understanding the risk of myelodysplastic syndrome and acute myeloid leukaemia.
    Tinker AV
    Lancet Haematol; 2021 Feb; 8(2):e97-e99. PubMed ID: 33347815
    [No Abstract]   [Full Text] [Related]  

  • 39. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
    Fujisawa S; Togawa J; Tanaka M; Koharazawa H; Aoba M; Fujita H; Murata T; Kanamori H; Matsuzaki M; Mohri H; Ishigatsubo Y
    Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosis.
    Mahoney DH; McClain KL; Hanson IC; Taylor LD; Steuber CP
    Am J Pediatr Hematol Oncol; 1989; 11(2):153-7. PubMed ID: 2546462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.